CliffBio
small molecule

RISPERIDONE

RISPERIDONE

Loss of exclusivity—loss of exclusivity
CompanyNovitium Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameRISPERIDONE
Active ingredientRISPERIDONE
Strength0.25MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2008
Marketing statusRX

More from Novitium Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.